2021?ê5ÃÃ27ÃÃÃÃÃ磬ÃÿÃúÃà ´«Ãë·¢ÃýÃúÃïçÃþ¿ÃùÃüóÃñÃþ¿Ã±Ã¦ÃÃúÃî½Ãæ¼½ÃÃõÃÃûÃ룬ÃÃÃúÃü¿Ãççú116ȇÃéÃÃêÃÃÃôøôÃùÃÃÃòÃïÃâÃ÷ÃÃûúÃ÷½ÃæµÃçÃõ½²Ãù¡£Ã¬Ã±£¬½²Ãùòè¹ýÃÃö»áÃéÃÃñ²¥µÃ·½Ã½ÃÃÃÃÃÃù¿ª¡£±¨¸æÃÃÃî½Ãæ¼½ÃÃÃÃ÷³Ã£¬»áÃéÃó¡ÃÃÃõÃþü¡¢ÃñᲨ¡¢Ãà ÃãµÃ½ÃÃü°¶þî¶à ÃûçÃú²Ã¼Ã£¬ÃÃÃÃñ²¥Ã²Ãý«½üý°ÃÃûìÃòüÃÃôôñ¨¸æ»á¡£
Â
       Ãý²ÃùÃã¬ÃüóÃñÃþ¿Ã±ÃðûÃÃÃâÃÃÃÃÃÃ¥NLRµ°°ÃÃ뿹²¡Ã¡ÃåêÃ÷ê¶ÃÃóÃòÃÃÃý²ÃöÃÃÃüÃÃÃÃòÃïÃâÃùý³ÃÃõÃÃÃêÃ÷Ãá£Ã²ÃïÃÃÃìÃâÃõÃûÃà ÃÃêÃé³Ã²¿·ÃÃÃçæµ°°ÃÃýÃðµÃÃÃÃìÃâÃã¨Effector-Triggered Immunity, ETI£©¡£NLR£¨Nucleotide-binding domain and leucine-rich repeat containing receptor£©Ãõ÷½ÃETIµÃûÃà Ã÷êÃÃÃåµ°°Ã¡£¸ù¾ÃNLRµ°°ÃµÃN¶Ã½á¹¹Ãò£¬NLRÃ÷ê·ÃêÃýÃà £ºTNL (TIR-NB-LRR)¡¢CNL (CC-NB-LRR) ¡¢RNL (RPW8-NB-LRR)¡£ÃâÃà ÃÃÃåµ°°Ã¶¼¿ÃÃÃñ½Ã»òÃüä½ÃµÃö±ð²¡Ã¾úçæµ°°Ã½ø¶øÃýÃðETI¡£NLRµ°°Ã¸´ºÃÃïµÃÃé𡢽ṹºÃ¹¦Ã÷ÃÃö£¬½ÃþÃÃNLRÃ÷Ãõùüü·ÃÃûúÃÃÃÃòÃïÃâÃÃÃþ¿µÃÃï³Ã±®Ãüþ¡£Ãþ¿°ûÃÃÃâÃÃÃÃÃåö±ð²¡ÃÂâÃúÃïçæµ°°ÃµÃ·ÃÃûúÃò»½öÃÃÃúÃÃÃÃÃÃÃýâòÃïÃ벡ÃÂâÃúÃï¼äµÃ½ø»¯¹Ãõ£¬»¹ÃÃêÃþ¿¶¯ÃïÃìûÃâÃûúÃÃÃṩÃÃÃ÷¡£
Â
       ÃüóÃñÃþ¿Ã±ÃÃZAR1¿¹²¡Ã¡ÃåêÃý£¬¸øÃÃÃý²ÃöÃÃûéÃûµÃÃþ¿³Ã¹û¡£¿¹²¡µ°°ÃZAR1ÃÃCNLÃà µ°°Ã£¬ZAR1ÃÃÃÃ¥Ã⼤»îºóÃéðêû¸öÃå¾ÃÃåµÃ¿¹²¡Ã¡ÃÃ¥(resistosome)¡£Ãþ¿ÃÃÃõ¥·ÃÃóÃÃñ·¢Ã㬼¤»îºóµÃZAR1µ°°Ã¿ÃÃÃÃÃòÃïø°ûäÃÃÃóÃÃå¾ÃÃ帴ºÃÃï¡£ÃÃ¥ÃâÃéðµÃZAR1¿¹²¡Ã¡Ãåñ½Ã²åÃëìê²ãÃ㬾ÃÃÃCa2+¿ÃèøÃõÃÃôÃëÃÃèµÃȔÃ㬲¢ÃøÃÃëÃÃèµÃȔÃÃÃÃõÃÃGlu11°±»ùÃá²Ã»ù¡£½øû²½Ãþ¿·¢Ã㬼¤»îºóµÃZAR1ÃÃòÃïø°ûÃôýøÃÃõÃÃGlu11µÃCa2+ÃÃÃ÷¡¢ÃÃø°û½á¹¹µÃÃà ¶¯¡¢»îÃÃÃõµÃ²úÃúºÃø°ûÃÃÃöµÃûõÃÃÃúÃ÷´Ã¦¡£Ãò´Ã£¬ZAR1¿¹²¡Ã¡Ãå¾ÃÃÃÃëÃÃèµÃȔÃã¬Ãä¶Ã¼¤»î¸ÃÃà ºà Ãü°ÃÃÃÃÃâÃ÷´Ã¦ºÃø°ûÃÃÃö²»¿Ã»òñ¡£
Â
       ±¨¸æ½áÃøºó£¬ÃáÃû·½ÃÃó¡Ãø·Ãî·ÃÃÃÃ磬ÃÃÃÃÃÃÃÃÃÃæºÃìçÃûý¼«¾Ã±¨¸æÃÃÃýøÃÃÃÃÃáÃã¬Ã²ÃÃìç¾Ãû·´Ãý½«ÃÃÃÃæµÃÃþ¿ÃýÃëÃüºµÃ¿ÃÃâÃò¢Ãá³öÃÃÃ⣬ÃüóÃñÃþ¿Ã±ÃÃÃõÃê´ó¼ÃÃö³öÃýâ´ð¡£ÃüóÃñÃþ¿Ã±¶Ãµ½µÃ¼û½âºÃçÃÃõÃÃüÂüìÃýÃðÃÃÃó¡Ã¦ÃúµÃÃî¿Ãü¿¼£¬¼Ã¼¤·¢ÃÿÃÃÃÃÃÃ飬ÃÿªÃÃÃÃçÃõÃÃ𣬱¾´ÃçÃõ½²ÃùòÃú½áÃø¡£
Â
版权与免责声明:本网页的内容由收集互联网上公开发布的信息整理获得。目的在于传递信息及分享,并不意味着赞同其观点或证实其真实性,也不构成其他建议。仅提供交流平台,不为其版权负责。如涉及侵权,请联系我们及时修改或删除。邮箱:sales@allpeptide.com